A case before the Supreme Court this week on medication abortion could affect not just reproductive health nationwide, but also oversight of the drug industry and the authority of federal agencies.
The case could affect not just abortion access but oversight of the drug industry and the authority of federal agencies. The court hears arguments Tuesday.
Preliminary numbers show 21.3 million American signed up for Obamacare this year — a huge increase since Biden took office. 15 million people, however, have also been kicked off of Medicaid.
The health care giant and the coalition of unions that walked out for three days earlier this month announced a contract deal that averts another strike.
Patients and doctors in Tennessee, Idaho and Oklahoma are taking legal action against state abortion bans. Women told dramatic stories of dangerous pregnancies and delayed care.
The government will negotiate new prices for the commonly prescribed drugs, but the cuts won’t take effect until 2026. In the meantime, drug makers are fighting the negotiations with lawsuits.